The Gene Synthesis Market is expanding rapidly as synthetic DNA becomes increasingly important across synthetic biology, drug discovery, vaccine development, genetic engineering, and advanced therapeutic research. The market was valued at USD 2.7 billion in 2025 and is projected to grow from USD 3.1 billion in 2026 to USD 9.3 billion by 2033, registering a CAGR of 16.7% from 2026 to 2033. Growing investments in genomics research, personalized medicine, and cell and gene therapies are creating new applications for customized DNA sequences.

Download a free sample copy of the Gene Synthesis market report to understand detailed coverage and inclusions in the final report

Market Growth and Demand Landscape

The increasing use of synthetic genes in drug discovery, vaccine development, synthetic biology, and genetic engineering is supporting market expansion. Continuous advancements in DNA synthesis technologies and declining synthesis costs are making gene synthesis increasingly useful for research and therapeutic development.

The rising demand for personalized medicine and precision therapeutics is another important growth factor. Gene synthesis supports the rapid design and production of customized DNA sequences for biomarker discovery, companion diagnostics, and advanced biologics. Increasing prevalence of cancer, rare genetic disorders, and chronic diseases is also encouraging the adoption of genomics-based approaches.

The market has additionally benefited from growing interest in synthetic biology research. Synthetic DNA technologies can support the rapid replication and analysis of genes of interest, creating opportunities in research involving emerging viruses, diagnostics, therapeutics, and vaccine development.

Method and Technology Insights

Solid-phase synthesis held the largest revenue share of 35.1% in 2025. It is widely used to create modified and canonical polymers of nucleic acids, including RNA and DNA, and is utilized across several research applications. Many commercial gene synthesis providers use solid-phase synthesis platforms.

PCR-based enzyme synthesis is expected to register the fastest CAGR during the forecast period. Its precision, ease of use, and reasonably priced technology are supporting adoption. The method can also support production of A+T-rich malaria genomes and significant quantities of labeled protein for NMR spectroscopy when conventional gene expression is difficult.

Chip-based synthesis represents another important technology within the market, enabling high-throughput and parallel production of oligonucleotides for genomics, synthetic biology, and research applications.

Service and Application Trends

Antibody DNA synthesis held the largest service share at 60.9% in 2025. Service providers support research institutions and biotechnology and pharmaceutical companies by enabling cloning and synthesis of antibody chain sequences into vectors. Viral gene synthesis is projected to witness the fastest growth, supported by increasing virus vector-related research and development activities.

By application, gene and cell therapy development represented the largest share at 35.2% in 2025. Synthetic genes support vector construction, target validation, cell engineering, and development of therapeutic candidates. The growing advanced therapies pipeline is therefore creating additional demand for gene synthesis technologies.

Disease diagnosis is anticipated to witness the fastest growth in the coming years. Synthetic biology can support molecular diagnostics, biomarker identification, assay development, and diagnostic test validation, particularly where emerging pathogens or rare diseases create challenges for conventional approaches.

End-use Market Landscape

Academic and government research institutes accounted for the largest end-use share at 54.4% in 2025 and are expected to grow at the fastest CAGR during the forecast period. Research institutions are increasingly collaborating with gene synthesis service providers to accelerate programs requiring gene fragment characterization and synthesis.

Biotechnology and pharmaceutical companies are also projected to witness significant growth as companies develop new platforms and technologies for synthetic biology, biologics, vaccines, and advanced therapeutics. Contract research organizations contribute to demand through outsourced research, preclinical studies, therapeutic development, and customized molecular biology projects.

Regional Market Outlook

North America dominated the market with a 37.5% revenue share in 2025. The region benefits from the presence of major gene synthesis service providers, strong interest in gene and cell therapy development, expanding synthetic biology activity, and a large number of contract research organizations.

Asia Pacific is projected to witness the fastest growth during the forecast period. Increasing research activities for effective therapeutics, growing interest in synthetic biology, improving healthcare infrastructure, entry of biotechnology organizations, and rising research and development activities are supporting expansion.

Competitive Landscape and Innovation

Technology development remains central to competition. Companies are working on automation, high-throughput synthesis, faster turnaround times, and high-fidelity DNA production. These developments are helping address evolving requirements across research, diagnostics, synthetic biology, and therapeutic development.

Market Challenges and Future Opportunities

Biosecurity concerns associated with the potential misuse of synthetic DNA technologies represent an important market restraint. Regulatory authorities have introduced oversight, screening protocols, and compliance requirements because of concerns surrounding unauthorized creation or modification of harmful pathogens. Such measures can increase operational costs, extend approval timelines, and create additional compliance requirements.

At the same time, expanding precision medicine, cell and gene therapy research, vaccine development, synthetic biology, and genomics is creating substantial opportunities. Continued technological advances and declining synthesis costs are expected to support further adoption across research and commercial applications.

Key Gene Synthesis Companies:

·        GenScript

·        Brooks Automation, Inc. (GENEWIZ)

·        Boster Biological Technology

·        Twist Bioscience

Explore the full list of profiled companies operating in this market with recent strategic initiatives

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.